The levels of AGR2, AKT, ERK and Ki67 were all decreased in pancreatic cancer with downregulated tumor promotors, which confirmed the oncogenic role of the above cytokines [24]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.